Skip to content
Biodatica
Start free

IMAGEN BIOWORKS INC.

HOUSTON, TX

OncologyGrant-only
Compare Sign in to watch

What changed

NIH R34 · $0.4M · Cross-Species comparison of cholinergic neuromodulation in mice and primates

5w agoGrant renewalJun 9, 2026Source filing (opens the source filing in a new tab)

Momentum

70no change

Momentum 70 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

13,060 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R01 · $768k · non-dilutive

    Sep 20, 2025

    ROCKEFELLER UNIVERSITY · PI VAZIRI, ALIPASHA · NIMH · award ends Jun 30, 2030 · Enabling high-fidelity population voltage imaging with next-generation optical platforms and indicators

    NIH RePORTER · NIH RePORTER 11243733 (opens the source filing in a new tab)

  2. Grant

    R41 · $349k · non-dilutive

    Sep 12, 2025

    IMAGEN BIOWORKS INC. · PI ST-PIERRE, FRANCOIS · NIGMS · award ends Aug 31, 2027 · Scalable spatiotemporal-omics platform

    NIH RePORTER · NIH RePORTER 11261705 (opens the source filing in a new tab)

  3. Grant

    R01 · $633k · non-dilutive

    Aug 1, 2025

    BAYLOR COLLEGE OF MEDICINE · PI REIMER, JACOB · NINDS · award ends Apr 30, 2030 · IN VIVO IMAGING OF STATE-DEPENDENT ASTROCYTE VOLTAGE DYNAMICS AND NEURAL ACTIVITY IN MOUSE VISUAL CORTEX

    NIH RePORTER · NIH RePORTER 11384921 (opens the source filing in a new tab)

  4. Grant

    R34 · $355k · non-dilutive

    Jun 3, 2025

    BAYLOR COLLEGE OF MEDICINE · PI REIMER, JACOB · NINDS · award ends May 31, 2027 · Cross-Species comparison of cholinergic neuromodulation in mice and primates

    NIH RePORTER · NIH RePORTER 11345165 (opens the source filing in a new tab)

  5. Grant

    R01 · $590k · non-dilutive

    Apr 17, 2024

    BAYLOR COLLEGE OF MEDICINE · PI ST-PIERRE, FRANCOIS · NINDS · award ends Mar 31, 2029 · Red-shifted voltage indicators for two-photon all-optical physiology and multi-spectral imaging

    NIH RePORTER · NIH RePORTER 11307158 (opens the source filing in a new tab)

  6. Grant

    R61 · $222k · non-dilutive

    Apr 1, 2024

    METHODIST HOSPITAL RESEARCH INSTITUTE · PI ROSTOMILY, ROBERT C · NCI · award ends Mar 31, 2027 · A multiplexed high-throughput platform to report pharmacologic alteration of cancer stem cell membrane potential and cell cycle state

    NIH RePORTER · NIH RePORTER 11314488 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources